Literature DB >> 26309345

Adrenal venous sampling in a patient with adrenal Cushing syndrome.

Carlos Esteban Builes-Montaño1, Carlos Andrés Villa-Franco2, Alejandro Román-Gonzalez3, Alejandro Velez-Hoyos4, Santiago Echeverri-Isaza5.   

Abstract

The primary bilateral macronodular adrenal hyperplasia or the independent adrenocorticotropic hormone bilateral nodular adrenal hyperplasia is a rare cause hypercortisolism, its diagnosis is challenging and there is no clear way to decide the best therapeutic approach. Adrenal venous sampling is commonly used to distinguish the source of hormonal production in patients with primary hyperaldosteronism. It could be a useful tool in this context because it might provide information to guide the treatment. We report the case of a patient with ACTH independent Cushing syndrome in whom the use of adrenal venous sampling with some modifications radically modified the treatment and allowed the diagnosis of a macronodular adrenal hyperplasia.

Entities:  

Keywords:  Cushing syndrome; adrenal cortex diseases; adrenal cortex function Tests

Mesh:

Substances:

Year:  2015        PMID: 26309345      PMCID: PMC4536821     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  10 in total

1.  Adrenal vein sampling for Primary Aldosteronism: time for a reality check.

Authors:  Paul M Stewart; Bruno Allolio
Journal:  Clin Endocrinol (Oxf)       Date:  2009-09-21       Impact factor: 3.478

2.  Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.

Authors:  Yuko Akehi; Hisaya Kawate; Kunitaka Murase; Ryoko Nagaishi; Takashi Nomiyama; Masatoshi Nomura; Ryoichi Takayanagi; Toshihiko Yanase
Journal:  Endocr J       Date:  2013-04-10       Impact factor: 2.349

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

Review 4.  ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications.

Authors:  S A Lieberman; T R Eccleshall; D Feldman
Journal:  Eur J Endocrinol       Date:  1994-07       Impact factor: 6.664

5.  Acth-independent Cushing's syndrome: bilateral cortisol-producing adrenal adenomas.

Authors:  S F Dinneen; J A Carney; P C Carpenter; C S Grant; W F Young
Journal:  Endocr Pract       Date:  1995 Mar-Apr       Impact factor: 3.443

Review 6.  Challenges in the diagnostic work-up and management of patients with subclinical Cushing's syndrome and bilateral adrenal masses.

Authors:  Adam Maghrabi; Abid Yaqub; Krista L Denning; Nesreen Benhamed; Saba Faiz; Tipu Saleem
Journal:  Endocr Pract       Date:  2013 May-Jun       Impact factor: 3.443

7.  The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses.

Authors:  William F Young; Hendrick du Plessis; Geoffrey B Thompson; Clive S Grant; David R Farley; Melanie L Richards; Dana Erickson; Adrian Vella; Anthony W Stanson; J Aidan Carney; Charles F Abboud; Paul C Carpenter
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 8.  ACTH-independent macronodular adrenal hyperplasia.

Authors:  André Lacroix
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

Review 9.  Primary bilateral macronodular adrenal hyperplasia.

Authors:  Agostino De Venanzi; Guilherme Asmar Alencar; Isabelle Bourdeau; Maria Candida Barisson Villares Fragoso; André Lacroix
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

10.  Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.

Authors:  Srividya Kidambi; Hershel Raff; James W Findling
Journal:  Eur J Endocrinol       Date:  2007-12       Impact factor: 6.664

  10 in total
  7 in total

1.  Intermittent Blurry Vision: An Unexpected Presentation of Cushing's Syndrome Due to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH).

Authors:  Christopher Fernandez; Smriti Bhatia; Ariana Rucker; Lee Celio
Journal:  Cureus       Date:  2022-05-15

Review 2.  ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures.

Authors:  Jia Wei; Sheyu Li; Qilin Liu; Yuchun Zhu; Nianwei Wu; Ying Tang; Qianrui Li; Kaiyun Ren; Qianying Zhang; Yerong Yu; Zhenmei An; Jing Chen; Jianwei Li
Journal:  BMC Endocr Disord       Date:  2018-04-23       Impact factor: 2.763

3.  Adrenal venous sampling in patients with ACTH-independent hypercortisolism.

Authors:  Eleni Papakokkinou; Hugo Jakobsson; Augustinas Sakinis; Andreas Muth; Bo Wängberg; Olof Ehn; Gudmundur Johannsson; Oskar Ragnarsson
Journal:  Endocrine       Date:  2019-08-22       Impact factor: 3.633

Review 4.  Recent Advances in the Clinical Application of Adrenal Vein Sampling.

Authors:  Shan Zhong; Tianyue Zhang; Minzhi He; Hanxiao Yu; Zhenjie Liu; Zhongyi Li; Xiaoxiao Song; Xiaohong Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-09       Impact factor: 5.555

Review 5.  Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation.

Authors:  Byung Kwan Park; Masashi Fujimori; Shu-Huei Shen; Uei Pua
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-01

6.  A case of adrenal Cushing's syndrome with bilateral adrenal masses.

Authors:  Ya-Wun Guo; Chii-Min Hwu; Justin Ging-Shing Won; Chia-Huei Chu; Liang-Yu Lin
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-05-01

7.  The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients.

Authors:  German Rubinstein; Andrea Osswald; Leah Theresa Braun; Frederick Vogel; Matthias Kroiss; Stefan Pilz; Sinan Deniz; Laura Aigner; Thomas Knösel; Jérôme Bertherat; Lucas Bouys; Roland Ladurner; Anna Riester; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2022-03-10       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.